IMARC Group, a leading market research company, has recently releases report titled “United States Transfection Technologies Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the United States transfection technologies market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
How big is the United States transfection technologies market?
The United States transfection technologies market size reached US$ 359 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 557 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.
What are transfection technologies?
Transfection technologies refer to a set of techniques used in molecular biology and biotechnology to introduce foreign genetic material, such as DNA or RNA, into a host cell. This process plays a crucial role in various research endeavors, including gene expression studies, protein production, and the development of therapeutic interventions. Transfection methods can be broadly categorized into two main types: transient and stable transfection. In transient transfection, genetic material is introduced into cells for a short period, allowing the temporary expression of the introduced genes. This method is valuable for studying gene function and regulation in a controlled environment. On the other hand, stable transfection results in the long-term integration of foreign genes into the genome of the host cell. This is particularly useful for applications like the production of recombinant proteins or the creation of cell lines with specific genetic modifications.
Request for a free sample copy of this report: https://www.imarcgroup.com/united-states-transfection-technologies-market/requestsample
What are the growth prospects and trends in the United States transfection technologies industry?
The growing interest in gene therapy as a potential cure for genetic disorders and various diseases is propelling the transfection devices market. Clinical trials and successful gene therapy treatments are increasing the demand for transfection technologies that can efficiently deliver therapeutic genes. Additionally, the pharmaceutical industry heavily relies on transfection technologies to develop and test new drugs. Transfection devices are essential for drug discovery, target validation, and the development of biologics, including monoclonal antibodies and vaccines.
Other than this, the presence of numerous academic and research institutions in the United States, engaged in cutting-edge genetic and molecular research, fuels the demand for transfection devices. These institutions require efficient tools to conduct experiments and advance scientific knowledge. Besides this, the rising incidence of genetic disorders and chronic diseases necessitates research into potential genetic treatments. Transfection technologies play a vital role in this research by enabling the delivery of therapeutic genes. In line with this, the continued growth of the biopharmaceutical industry, including the production of recombinant proteins and monoclonal antibodies, relies on transfection devices for cell line development and protein expression.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product Type:
Breakup by Application:
- Therapeutic Delivery
- Bio-Medical Research
- Protein Production
Breakup by Transfection Method:
- Cationic Lipid Transfection
- In-Vivo Transfection
Breakup by Technology:
- Physical Transfection
- Biochemical Based Transfection
- Viral-Vector Based Transfection
Breakup by End User:
- Research Centers and Academic Institutes
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
Breakup by Region:
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Follow us on Twitter: @imarcglobal